Weekly signal · GH · Healthcare

Guardant Health Inc (GH) carries a 38.7% four-week climb into weekly view

The precision-oncology testing stock remains in an active weekly trend, but volume and relative-strength readings keep the confirmation from looking one-sided.

Guardant Health Inc
Latest131.62 USD
1W move4.8%
Volume0.9x
TrendActive
Precision oncology diagnostics lab with blood samples and market data screen representing Guardant Health.

Market update

What happened

Guardant Health Inc (GH) finished the latest week at 131.62 USD, up 4.8%, with the healthcare diagnostics name extending a broader advance in weekly market data.

The move is backed by an active trend signal and Market Dynamics confirmation at 1.11. The evidence is not uniformly strong: latest weekly volume of 9.28 million shares was below the 13-week average of 10.55 million, while Relative Strength stood at 32.6.

The chart shows the weekly price path over 52 weeks, so the setup reflects medium-term context rather than live intraday action.

Continue your research

Explore GH across Sharemaestro

These links are shown because current Sharemaestro data is available for this company.

Interactive chartReview weekly price, Trend Line, Fair Value, volume and Relative Strength.Full weekly reportOpen the full company report, financial profile and peer comparison.Technical analysisExamine support, resistance, momentum and the current trend readings.Stage analysisSee whether the stock is basing, advancing, distributing or declining.Trend historyReview how long the current trend has persisted and where it has changed.Sector comparisonCompare sector returns, breadth, leaders and weaker areas.Industry comparisonSee how this company’s industry is performing across its members.Company factorsCompare value, quality, growth, momentum and financial strength.News sentimentSee the balance, quality and freshness of recent company coverage.Buying and selling pressureReview longer-term accumulation, distribution and reversal readings.EarningsReview report dates, estimates, past results and earnings surprises.Options activitySee options positioning, expected move and unusual trading activity.Short interestReview short positioning, crowding and possible squeeze risk.Insider transactionsSee reported purchases and sales by company directors and executives.

GH coverage

Evidence context